Literature DB >> 15626706

The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes.

Marjorie Bon Homme1, Carol Carter, Suzanne Scarlata.   

Abstract

Assembly of the HIV-1 virus involves, in part, strong interactions between the capsid (CA) domains of the Gag polyprotein. During maturation, the core of HIV-1 virions undergoes profound morphological changes due primarily to proteolysis of the CA domain from other Gag domains which may allow for more efficient disassembly of the viral core in the early stages of infection. The host protein cyclophilin A (CypA), a cis-trans prolyl isomerase, in some way seems to assist in this assembly/disassembly process. Using an unproteolyzed construct of CA, we show that binding of CypA induces a large-scale conformational change in CA that is independent of its cis-trans prolyl isomerase activity. This change appears to be mediated by Cys-198 of CA since mutation to Ala renders CypA unable to induce this change and alters the kinetics and stability of protein cores that may ultimately result in inefficient disassembly of viral cores. Alternately, mutation of the second CA Cys (C218A) allows for CypA-induced conformational changes but alters the kinetics and morphology of the protein cores that may ultimately result in inefficient assembly of viral cores. These studies show the importance of the CA Cys residues in mediating the contacts needed for viral assembly and disassembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15626706      PMCID: PMC1305260          DOI: 10.1529/biophysj.104.053298

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  36 in total

1.  HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes.

Authors:  L S Ehrlich; T Liu; S Scarlata; B Chu; C A Carter
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

2.  Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.

Authors:  L Dietrich; L S Ehrlich; T J LaGrassa; D Ebbets-Reed; C Carter
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro.

Authors:  Jason Lanman; Jennifer Sexton; Michael Sakalian; Peter E Prevelige
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  The pH dependence of HIV-1 capsid assembly and its interaction with cyclophilin A.

Authors:  Marjorie Bon Homme; Stanislaus Wong; Carol Carter; Suzanne Scarlata
Journal:  Biophys Chem       Date:  2003-08-01       Impact factor: 2.352

5.  Host cyclophilin A mediates HIV-1 attachment to target cells via heparans.

Authors:  A C Saphire; M D Bobardt; P A Gallay
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

6.  Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.

Authors:  Daryl A Bosco; Elan Z Eisenmesser; Susan Pochapsky; Wesley I Sundquist; Dorothee Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

7.  Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain.

Authors:  M M Endrich; P Gehrig; H Gehring
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

8.  Structural insights into the catalytic mechanism of cyclophilin A.

Authors:  Bruce R Howard; Felix F Vajdos; Su Li; Wesley I Sundquist; Christopher P Hill
Journal:  Nat Struct Biol       Date:  2003-06

Review 9.  Role of HIV-1 Gag domains in viral assembly.

Authors:  Suzanne Scarlata; Carol Carter
Journal:  Biochim Biophys Acta       Date:  2003-07-11

10.  A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.

Authors:  Chen Liang; Jing Hu; James B Whitney; Lawrence Kleiman; Mark A Wainberg
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  5 in total

Review 1.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

2.  Structure of a monomeric mutant of the HIV-1 capsid protein.

Authors:  Ronald Shin; Ywh-Min Tzou; N Rama Krishna
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

3.  Discovery of Dehydroamino Acid Residues in the Capsid and Matrix Structural Proteins of HIV-1.

Authors:  Rachel M Miller; Rachel A Knoener; Bayleigh E Benner; Brian L Frey; Mark Scalf; Michael R Shortreed; Nathan M Sherer; Lloyd M Smith
Journal:  J Proteome Res       Date:  2022-02-22       Impact factor: 4.466

4.  Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.

Authors:  Luciano Vozzolo; Belinda Loh; Paul J Gane; Maryame Tribak; Lihong Zhou; Ian Anderson; Elisabeth Nyakatura; Richard G Jenner; David Selwood; Ariberto Fassati
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

5.  Characterization of the in vitro HIV-1 capsid assembly pathway.

Authors:  Eric Barklis; Ayna Alfadhli; Carolyn McQuaw; Suraj Yalamuri; Amelia Still; Robin Lid Barklis; Ben Kukull; Claudia S López
Journal:  J Mol Biol       Date:  2009-02-03       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.